InvestorsHub Logo
Followers 556
Posts 17586
Boards Moderated 4
Alias Born 01/02/2005

Re: None

Thursday, 04/24/2008 5:06:14 PM

Thursday, April 24, 2008 5:06:14 PM

Post# of 2463
Vivaglobin sales are going quite well. Most of REPR's sales for the Freedom60 are for Vivaglobin use. Here is what CSL, the maker of Vivaglobin, stated about Vivaglobin sales:

Immunoglobulins grew 26% in US dollar terms with Carimune® / Sandoglobulin® (Intravenous Immunoglobulin), Vivaglobin® (subcutaneous Immunoglobulin) and Rhophylac® (used in the prevention of haemolytic disease of the new born) performing particularly well. Vivaglobin®, which provides patients with the convenience of self administration of immunoglobulin, attracted significant new patient demand.

http://www.csl.com.au/docs/358/504/1H08%20ASX%20release%20FINAL.pdf

Mike